10199-SPDR-2 PERSONALIZED SYNTHETIC LETHALITY INDUCED BY TARGETING ATR-CHK1 IN MEDULLOBLASTOMAS IDENTIFIED BY IMPLEMENTATION OF SLFN11 IMMUNOHISTOCHEMISTRY

Satoshi Nakata(Gunma University), Masahiko Tosaka(Gunma University), Sumihito Nobusawa(Gunma University), Masayasu Okada(Niigata University Medical and Dental Hospital), Manabu Natsumeda(Niigata University), Junko Murai(Ehime University), Aki NAKATA(Gunma University), Hideaki Yashima(Gunma University), Takuya Araki(Gunma University)

Neuro-Oncology Advances

December 1, 2023

10.1093/noajnl/vdad141.077

Cited by 0

Related Papers

Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition

|Oncotarget|2016|292

CNS high‐grade neuroepithelial tumor with <i>BCOR</i> internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue

|Brain Pathology|2017|125

<i>SLFN11</i> Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma

|Clinical Cancer Research|2015|103

Fractionation of Nitrogen Isotopes during the Uptake and Assimilation of Ammonia<italic><xref ref-type="fn" rid="fn1"><sup>l</sup></xref></italic> by Plants

|Plant and Cell Physiology|1991|98

<i>BRAF</i> V600E, <i>TERT</i> promoter mutations and <i>CDKN2A/B</i> homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity

|Brain Pathology|2017|78